Skip to main content
Top
Published in: Journal of Gastroenterology 6/2018

01-06-2018 | Letter to the Editor

Reply to the letter to the editor: Lymph node metastasis of adenocarcinoma and different definitions of sm1 cancer in the esophagus

Authors: Ryu Ishihara, Tsuneo Oyama, Seiichiro Abe, Hiroaki Takahashi, Hiroyuki Ono, Junko Fujisaki, Mitsuru Kaise, Kenichi Goda, Kenro Kawada, Tomoyuki Koike, Manabu Takeuchi, Rie Matsuda, Dai Hirasawa, Masayoshi Yamada, Junichi Kodaira, Masaki Tanaka, Masami Omae, Akira Matsui, Takashi Kanesaka, Akiko Takahashi, Shinichi Hirooka, Masahiro Saito, Yosuke Tsuji, Yuki Maeda, Hiroharu Yamashita, Ichiro Oda, Yasuhiko Tomita, Takashi Matsunaga, Shuji Terai, Soji Ozawa, Tatsuyuki Kawano, Yasuyuki Seto

Published in: Journal of Gastroenterology | Issue 6/2018

Login to get access

Excerpt

Thank you for your very helpful comments. We totally understand Dr. Takubo’s points. The diagnosis of cancer invasion depth may differ substantially between surgical specimen which is cut into 5-mm slices and endoscopic resected specimen which is cut into 2-mm slices. This difference may lead to misinterpretation of metastatic rate. We therefore show individual data of surgical specimens and endoscopic resected specimens in Tables 1 and 2.
Table 1
Rate of metastasis in surgical specimens
 
LVI (−) and poorly comp (−)
LVI (+) or poorly comp (+)
≤ 3 cm
3 cm <
SMM
0% (0/13 lesions)
0% (0/1 lesions)
0% (0/0 lesions)
LPM
0% (0/10 lesions)
0% (0/4 lesions)
0% (0/0 lesions)
DMM
0% (0/15 lesions)
0% (0/3 lesions)
83.3% (5/6 lesions)
SM 1–500 µm
0% (0/8 lesions)
0% (0/5 lesions)
30% (3/10 lesions)
SM 500 µm
9.5% (2/21 lesions)
23.1% (3/13 lesions)
40.7% (44/108 lesions)
Table 2
Rate of metastasis in endoscopic resected specimens
 
LVI (−) and poorly comp (−)
LVI (+) or poorly comp (+)
≤ 3 cm
3 cm <
SMM
0% (0/31 lesions)
0% (0/5 lesions)
0% (0/1 lesions)
LPM
0% (0/31 lesions)
0% (0/3 lesions)
0% (0/2 lesions)
DMM
0% (0/67 lesions)
0% (0/3 lesions)
44.4% (4/9 lesions)
SM 1–500 µm
0% (0/24 lesions)
25.0% (1/4 lesions)
0% (0/8 lesions)
SM 500 µm
7.1% (1/14 lesions)
20.0% (1/5 lesions)
23.5(8/34 lesions)
Metadata
Title
Reply to the letter to the editor: Lymph node metastasis of adenocarcinoma and different definitions of sm1 cancer in the esophagus
Authors
Ryu Ishihara
Tsuneo Oyama
Seiichiro Abe
Hiroaki Takahashi
Hiroyuki Ono
Junko Fujisaki
Mitsuru Kaise
Kenichi Goda
Kenro Kawada
Tomoyuki Koike
Manabu Takeuchi
Rie Matsuda
Dai Hirasawa
Masayoshi Yamada
Junichi Kodaira
Masaki Tanaka
Masami Omae
Akira Matsui
Takashi Kanesaka
Akiko Takahashi
Shinichi Hirooka
Masahiro Saito
Yosuke Tsuji
Yuki Maeda
Hiroharu Yamashita
Ichiro Oda
Yasuhiko Tomita
Takashi Matsunaga
Shuji Terai
Soji Ozawa
Tatsuyuki Kawano
Yasuyuki Seto
Publication date
01-06-2018
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 6/2018
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-018-1463-1

Other articles of this Issue 6/2018

Journal of Gastroenterology 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.